HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

lovastatin-niacin combination

niacin extended-release and lovastatin tablets

Also Known As:

Advicor

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Drug Context: Research Results

Experts

1.	Cefali, E: 1 article (09/2007)
2.	Menon, R: 1 article (09/2007)
3.	Tolbert, D: 1 article (09/2007)
4.	Bays, Harold E: 1 article (07/2004)
5.	Gupta, Eric K: 1 article (03/2002)
6.	Ito, Matthew K: 1 article (03/2002)

Related Diseases

1.	Dyslipidemias (Dyslipidemia) 03/01/2002 - "Only two slowly absorbed niacin products have been approved by the FDA for the treatment of dyslipidemia; they are Niaspan (Kos Pharmaceuticals, Inc., Miami, FL) and Advicor (Kos Pharmaceuticals, Inc., Miami, FL). " 09/01/2007 - "Lovastatin and extended-release (ER) niacin in a fixed dose combination (Advicor) is approved for the treatment of dyslipidemia. " 07/01/2004 - "This review summarizes the efficacy and safety of extended-release niacin/lovastatin (Advicor, Kos Pharmaceuticals Inc.), the first combination product approved for the management of dyslipidemia."
2.	Hyperlipidemias (Hyperlipidemia) 03/01/2002 - "Advicor (lovastatin and extended-release niacin) is the first cholesterol-lowering combination product to become available for the management of hyperlipidemia. "

Related Drugs and Biologics

1.	Niacin (Nicotinic Acid)
2.	Lovastatin (Mevacor)
3.	Cholesterol